These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
114 related articles for article (PubMed ID: 26930412)
1. DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis. Vici P; Buglioni S; Sergi D; Pizzuti L; Di Lauro L; Antoniani B; Sperati F; Terrenato I; Carosi M; Gamucci T; Dattilo R; Bartucci M; Vincenzoni C; Mariani L; Vizza E; Sanguineti G; Gadducci A; Vitale I; Barba M; De Maria R; Mottolese M; Maugeri-Saccà M PLoS One; 2016; 11(3):e0149872. PubMed ID: 26930412 [TBL] [Abstract][Full Text] [Related]
2. Predictive significance of DNA damage and repair biomarkers in triple-negative breast cancer patients treated with neoadjuvant chemotherapy: An exploratory analysis. Vici P; Di Benedetto A; Ercolani C; Pizzuti L; Di Lauro L; Sergi D; Sperati F; Terrenato I; Dattilo R; Botti C; Fabi A; Ramieri MT; Mentuccia L; Marinelli C; Iezzi L; Gamucci T; Natoli C; Vitale I; Barba M; Mottolese M; De Maria R; Maugeri-Saccà M Oncotarget; 2015 Dec; 6(40):42773-80. PubMed ID: 26544894 [TBL] [Abstract][Full Text] [Related]
3. Body mass index modifies the relationship between γ-H2AX, a DNA damage biomarker, and pathological complete response in triple-negative breast cancer. Barba M; Vici P; Pizzuti L; Di Lauro L; Sergi D; Di Benedetto A; Ercolani C; Sperati F; Terrenato I; Botti C; Mentuccia L; Iezzi L; Gamucci T; Natoli C; Vitale I; Mottolese M; De Maria R; Maugeri-Saccà M BMC Cancer; 2017 Feb; 17(1):101. PubMed ID: 28166748 [TBL] [Abstract][Full Text] [Related]
4. DNA damage repair and survival outcomes in advanced gastric cancer patients treated with first-line chemotherapy. Ronchetti L; Melucci E; De Nicola F; Goeman F; Casini B; Sperati F; Pallocca M; Terrenato I; Pizzuti L; Vici P; Sergi D; Di Lauro L; Amoreo CA; Gallo E; Diodoro MG; Pescarmona E; Vitale I; Barba M; Buglioni S; Mottolese M; Fanciulli M; De Maria R; Maugeri-Saccà M Int J Cancer; 2017 Jun; 140(11):2587-2595. PubMed ID: 28233295 [TBL] [Abstract][Full Text] [Related]
5. DNA damage response following X-irradiation in oral cancer cell lines HSC3 and HSC4. Jiaranuchart S; Kaida A; Onozato Y; Harada H; Miura M Arch Oral Biol; 2018 Jun; 90():1-8. PubMed ID: 29522917 [TBL] [Abstract][Full Text] [Related]
6. Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells. Vera J; Raatz Y; Wolkenhauer O; Kottek T; Bhattacharya A; Simon JC; Kunz M Cell Signal; 2015 May; 27(5):951-60. PubMed ID: 25683911 [TBL] [Abstract][Full Text] [Related]
7. MDC1 is a mediator of the mammalian DNA damage checkpoint. Stewart GS; Wang B; Bignell CR; Taylor AM; Elledge SJ Nature; 2003 Feb; 421(6926):961-6. PubMed ID: 12607005 [TBL] [Abstract][Full Text] [Related]
8. Radiosensitization of metformin in pancreatic cancer cells via abrogating the G2 checkpoint and inhibiting DNA damage repair. Wang Z; Lai ST; Ma NY; Deng Y; Liu Y; Wei DP; Zhao JD; Jiang GL Cancer Lett; 2015 Dec; 369(1):192-201. PubMed ID: 26304716 [TBL] [Abstract][Full Text] [Related]
9. Mitotic DNA damages induced by carbon-ion radiation incur additional chromosomal breaks in polyploidy. Li P; Zhou L; Liu X; Jin X; Zhao T; Ye F; Liu X; Hirayama R; Li Q Toxicol Lett; 2014 Oct; 230(1):36-47. PubMed ID: 25123929 [TBL] [Abstract][Full Text] [Related]
10. DNA-PKcs plays a dominant role in the regulation of H2AX phosphorylation in response to DNA damage and cell cycle progression. An J; Huang YC; Xu QZ; Zhou LJ; Shang ZF; Huang B; Wang Y; Liu XD; Wu DC; Zhou PK BMC Mol Biol; 2010 Mar; 11():18. PubMed ID: 20205745 [TBL] [Abstract][Full Text] [Related]
11. Influence of chk1 and plk1 silencing on radiation- or cisplatin-induced cytotoxicity in human malignant cells. Gao Q; Huang X; Tang D; Cao Y; Chen G; Lu Y; Zhuang L; Wang S; Xu G; Zhou J; Ma D Apoptosis; 2006 Oct; 11(10):1789-800. PubMed ID: 16927022 [TBL] [Abstract][Full Text] [Related]
12. Molecular markers of DNA damage and repair in cervical cancer patients treated with cisplatin neoadjuvant chemotherapy: an exploratory study. Real NE; Castro GN; Darío Cuello-Carrión F; Perinetti C; Röhrich H; Cayado-Gutiérrez N; Guerrero-Gimenez ME; Ciocca DR Cell Stress Chaperones; 2017 Nov; 22(6):811-822. PubMed ID: 28608263 [TBL] [Abstract][Full Text] [Related]
13. The checkpoint 1 kinase inhibitor LY2603618 induces cell cycle arrest, DNA damage response and autophagy in cancer cells. Wang FZ; Fei HR; Cui YJ; Sun YK; Li ZM; Wang XY; Yang XY; Zhang JG; Sun BL Apoptosis; 2014 Sep; 19(9):1389-98. PubMed ID: 24928205 [TBL] [Abstract][Full Text] [Related]
14. Chk1 is a wee1 kinase in the G2 DNA damage checkpoint inhibiting cdc2 by Y15 phosphorylation. O'Connell MJ; Raleigh JM; Verkade HM; Nurse P EMBO J; 1997 Feb; 16(3):545-54. PubMed ID: 9034337 [TBL] [Abstract][Full Text] [Related]
15. Wee1 inhibition potentiates Wip1-dependent p53-negative tumor cell death during chemotherapy. Clausse V; Goloudina AR; Uyanik B; Kochetkova EY; Richaud S; Fedorova OA; Hammann A; Bardou M; Barlev NA; Garrido C; Demidov ON Cell Death Dis; 2016 Apr; 7(4):e2195. PubMed ID: 27077811 [TBL] [Abstract][Full Text] [Related]
16. Osteoblasts survive the arsenic trioxide treatment by activation of ATM-mediated pathway. Hu YC; Hsieh BS; Cheng HL; Huang LW; Huang TC; Huang IY; Chang KL Biochem Pharmacol; 2013 Apr; 85(7):1018-26. PubMed ID: 23337567 [TBL] [Abstract][Full Text] [Related]
17. Chk1 is dispensable for G2 arrest in response to sustained DNA damage when the ATM/p53/p21 pathway is functional. Lossaint G; Besnard E; Fisher D; Piette J; Dulić V Oncogene; 2011 Oct; 30(41):4261-74. PubMed ID: 21532626 [TBL] [Abstract][Full Text] [Related]
18. Oxaliplatin regulates DNA repair responding to ionizing radiation and enhances radiosensitivity of human cervical cancer cells. Yang YC; Chao KS; Lin CP; Chen YY; Wang KL; Chen YJ Int J Gynecol Cancer; 2009 May; 19(4):782-6. PubMed ID: 19509588 [TBL] [Abstract][Full Text] [Related]